Use of recombinant feline interferon and glucocorticoid in the treatment of feline infectious peritonitis

A total of 12 clinically ill cats previously diagnosed as feline infectious peritonitis (FIP) were treated with a combination of recombinant feline interferon and glucocorticoid. A complete remission (over 2 years) and a partial remission (2 to 5 months) were observed in four (33.3%) and four (33.3%...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishida, T, Shibanai, A, Tanaka, S, Uchida, K, Mochizuki, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: ESFM and AAFP. Published by Elsevier Ltd. 2004
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129501/
https://www.ncbi.nlm.nih.gov/pubmed/15123155
http://dx.doi.org/10.1016/j.jfms.2003.08.011
_version_ 1783516800052363264
author Ishida, T
Shibanai, A
Tanaka, S
Uchida, K
Mochizuki, M
author_facet Ishida, T
Shibanai, A
Tanaka, S
Uchida, K
Mochizuki, M
author_sort Ishida, T
collection PubMed
description A total of 12 clinically ill cats previously diagnosed as feline infectious peritonitis (FIP) were treated with a combination of recombinant feline interferon and glucocorticoid. A complete remission (over 2 years) and a partial remission (2 to 5 months) were observed in four (33.3%) and four (33.3%) cases, respectively. Those that survived for more than 2 years were all older cats (6 to 16 years old) with the effusive form of FIP.
format Online
Article
Text
id pubmed-7129501
institution National Center for Biotechnology Information
language English
publishDate 2004
publisher ESFM and AAFP. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-71295012020-04-08 Use of recombinant feline interferon and glucocorticoid in the treatment of feline infectious peritonitis Ishida, T Shibanai, A Tanaka, S Uchida, K Mochizuki, M J Feline Med Surg Article A total of 12 clinically ill cats previously diagnosed as feline infectious peritonitis (FIP) were treated with a combination of recombinant feline interferon and glucocorticoid. A complete remission (over 2 years) and a partial remission (2 to 5 months) were observed in four (33.3%) and four (33.3%) cases, respectively. Those that survived for more than 2 years were all older cats (6 to 16 years old) with the effusive form of FIP. ESFM and AAFP. Published by Elsevier Ltd. 2004-04 2004-02-25 /pmc/articles/PMC7129501/ /pubmed/15123155 http://dx.doi.org/10.1016/j.jfms.2003.08.011 Text en Copyright © 2004 ESFM and AAFP. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Ishida, T
Shibanai, A
Tanaka, S
Uchida, K
Mochizuki, M
Use of recombinant feline interferon and glucocorticoid in the treatment of feline infectious peritonitis
title Use of recombinant feline interferon and glucocorticoid in the treatment of feline infectious peritonitis
title_full Use of recombinant feline interferon and glucocorticoid in the treatment of feline infectious peritonitis
title_fullStr Use of recombinant feline interferon and glucocorticoid in the treatment of feline infectious peritonitis
title_full_unstemmed Use of recombinant feline interferon and glucocorticoid in the treatment of feline infectious peritonitis
title_short Use of recombinant feline interferon and glucocorticoid in the treatment of feline infectious peritonitis
title_sort use of recombinant feline interferon and glucocorticoid in the treatment of feline infectious peritonitis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129501/
https://www.ncbi.nlm.nih.gov/pubmed/15123155
http://dx.doi.org/10.1016/j.jfms.2003.08.011
work_keys_str_mv AT ishidat useofrecombinantfelineinterferonandglucocorticoidinthetreatmentoffelineinfectiousperitonitis
AT shibanaia useofrecombinantfelineinterferonandglucocorticoidinthetreatmentoffelineinfectiousperitonitis
AT tanakas useofrecombinantfelineinterferonandglucocorticoidinthetreatmentoffelineinfectiousperitonitis
AT uchidak useofrecombinantfelineinterferonandglucocorticoidinthetreatmentoffelineinfectiousperitonitis
AT mochizukim useofrecombinantfelineinterferonandglucocorticoidinthetreatmentoffelineinfectiousperitonitis

Ejemplares similares